Orbimed Advisors Has Cut Incyte (INCY) Holding; Aflac (AFL) Had 3 Bulls

February 19, 2018 - By Clifton Ray

Among 19 analysts covering Aflac Incorporated (NYSE:AFL), 3 have Buy rating, 4 Sell and 12 Hold. Therefore 16% are positive. Aflac Incorporated had 52 analyst reports since August 12, 2015 according to SRatingsIntel. RBC Capital Markets maintained it with “Sell” rating and $71.0 target in Tuesday, September 5 report. The stock of Aflac Incorporated (NYSE:AFL) has “Hold” rating given on Thursday, December 21 by Keefe Bruyette & Woods. Bank of America upgraded the shares of AFL in report on Thursday, April 6 to “Neutral” rating. The firm earned “Sector Perform” rating on Tuesday, February 2 by RBC Capital Markets. The rating was maintained by RBC Capital Markets with “Underperform” on Thursday, February 2. On Thursday, February 4 the stock rating was maintained by Citigroup with “Buy”. The stock of Aflac Incorporated (NYSE:AFL) has “Buy” rating given on Thursday, September 10 by Citigroup. The rating was maintained by Keefe Bruyette & Woods on Monday, October 12 with “”. Citigroup downgraded the stock to “Sell” rating in Tuesday, September 26 report. The company was maintained on Sunday, November 26 by Keefe Bruyette & Woods. See Aflac Incorporated (NYSE:AFL) latest ratings:

01/02/2018 Broker: Sandler O’Neill Rating: Hold New Target: $95.0 Maintain
01/02/2018 Broker: SunTrust Rating: Hold New Target: $92.0 Maintain
01/02/2018 Broker: RBC Capital Markets Rating: Sell New Target: $82.0 Maintain
22/01/2018 Broker: Raymond James Rating: Buy New Target: $100.0 Upgrade
16/01/2018 Broker: Janney Capital Rating: Buy
08/01/2018 Broker: Barclays Capital Rating: Hold New Target: $90.0
09/01/2018 Broker: Wells Fargo Rating: Hold New Target: $90.0 Maintain
21/12/2017 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $96.0 Maintain
26/11/2017 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $85.0 Maintain
13/11/2017 Broker: Morgan Stanley Rating: Equal-Weight Old Target: $80 New Target: $83 Maintain




Orbimed Advisors Llc decreased Incyte Corp (INCY) stake by 11.27% reported in 2017Q3 SEC filing. Orbimed Advisors Llc sold 187,400 shares as Incyte Corp (INCY)’s stock rose 9.08%. The Orbimed Advisors Llc holds 1.48 million shares with $172.31 million value, down from 1.66M last quarter. Incyte Corp now has $18.16 billion valuation. The stock increased 0.51% or $0.44 during the last trading session, reaching $86.03. About 2.47 million shares traded or 46.16% up from the average. Incyte Corporation (NASDAQ:INCY) has risen 72.84% since February 19, 2017 and is uptrending. It has outperformed by 56.14% the S&P500.

Since September 19, 2017, it had 0 insider purchases, and 5 sales for $2.40 million activity. HUDSON ELIZABETH J sold 1,279 shares worth $107,132. On Thursday, October 26 the insider TILLMAN AUDREY B sold $25,907. The insider CLONINGER KRISS III sold 25,000 shares worth $2.10M. $125,363 worth of Aflac Incorporated (NYSE:AFL) was sold by JOHNSON DOUGLAS WAYNE. 620 shares valued at $50,525 were sold by Daniels James Todd on Friday, September 29.

Investors sentiment decreased to 0.89 in Q3 2017. Its down 0.08, from 0.97 in 2017Q2. It is negative, as 44 investors sold Aflac Incorporated shares while 297 reduced holdings. 73 funds opened positions while 232 raised stakes. 250.65 million shares or 1.32% less from 254.01 million shares in 2017Q2 were reported. Daiwa Secs Gp Inc Inc has invested 0.02% in Aflac Incorporated (NYSE:AFL). 4,450 are owned by Texas Yale Corp. Cwm Ltd Liability holds 1,395 shares. Moreover, Commonwealth Retail Bank Of Australia has 0.06% invested in Aflac Incorporated (NYSE:AFL) for 71,641 shares. The Massachusetts-based Choate Inv Advsrs has invested 0.26% in Aflac Incorporated (NYSE:AFL). Andra Ap stated it has 0.15% in Aflac Incorporated (NYSE:AFL). Ajo L P stated it has 0.91% of its portfolio in Aflac Incorporated (NYSE:AFL). Drexel Morgan And has invested 0.21% of its portfolio in Aflac Incorporated (NYSE:AFL). Johnson Financial Group Inc reported 8,677 shares. 32,143 are held by Commonwealth Of Pennsylvania School Empls Retrmt Systems. Hillsdale Investment Mngmt invested in 0.06% or 4,650 shares. Boston Limited Liability Corporation stated it has 0.03% in Aflac Incorporated (NYSE:AFL). Magnetar Finance Lc stated it has 0.08% of its portfolio in Aflac Incorporated (NYSE:AFL). Eads And Heald Invest Counsel holds 25,504 shares or 1.29% of its portfolio. Synovus has 1.03% invested in Aflac Incorporated (NYSE:AFL) for 667,342 shares.

The stock increased 1.39% or $1.23 during the last trading session, reaching $89.65. About 2.14M shares traded. Aflac Incorporated (NYSE:AFL) has risen 7.68% since February 19, 2017 and is uptrending. It has underperformed by 9.02% the S&P500.

Aflac Incorporated, through its subsidiary, American Family Life Assurance Company of Columbus, provides supplemental health and life insurance products. The company has market cap of $35.00 billion. It operates through two divisions, Aflac Japan and Aflac U.S. It has a 8.18 P/E ratio. The Aflac Japan segment offers various voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan.

Since August 29, 2017, it had 1 insider buy, and 7 selling transactions for $292,287 activity. $250,068 worth of Incyte Corporation (NASDAQ:INCY) was sold by Siegel Eric H. on Friday, September 1. On Friday, September 8 BAKER BROS. ADVISORS LP bought $13.20M worth of Incyte Corporation (NASDAQ:INCY) or 100,000 shares. 714 shares valued at $88,715 were sold by Flannelly Barry P on Wednesday, September 13. 70,502 shares were sold by Hoppenot Herve, worth $8.42 million. 2,111 shares were sold by Stein Steven H, worth $263,875 on Tuesday, August 29. Shares for $668,361 were sold by GRYSKA DAVID W on Friday, January 5. SWAIN PAULA J had sold 20,000 shares worth $2.80M.

Orbimed Advisors Llc increased Anthem Inc (NYSE:ANTM) stake by 7,000 shares to 927,618 valued at $176.14 million in 2017Q3. It also upped Clovis Oncology Inc (NASDAQ:CLVS) stake by 284,300 shares and now owns 2.39M shares. Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) was raised too.

Among 24 analysts covering Incyte (NASDAQ:INCY), 20 have Buy rating, 0 Sell and 4 Hold. Therefore 83% are positive. Incyte had 78 analyst reports since August 6, 2015 according to SRatingsIntel. Leerink Swann maintained Incyte Corporation (NASDAQ:INCY) on Thursday, November 12 with “Outperform” rating. The rating was initiated by Credit Suisse with “Outperform” on Wednesday, January 20. UBS maintained it with “Buy” rating and $130 target in Wednesday, August 5 report. Oppenheimer maintained the shares of INCY in report on Tuesday, July 25 with “Hold” rating. The firm has “Overweight” rating by Barclays Capital given on Wednesday, August 2. The firm has “Buy” rating by Zacks given on Wednesday, August 12. Brean Capital maintained the shares of INCY in report on Wednesday, August 5 with “Buy” rating. On Wednesday, September 2 the stock rating was maintained by Brean Capital with “Buy”. The rating was maintained by BMO Capital Markets with “Buy” on Monday, September 11. The stock of Incyte Corporation (NASDAQ:INCY) earned “Outperform” rating by Cowen & Co on Tuesday, August 18.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.